Literature DB >> 25441308

Adenocarcinoma of the pancreas.

Ralph H Hruban1, David S Klimstra2.   

Abstract

Infiltrating ductal adenocarcinoma of the pancreas is a real enigma. On one hand, it is one of the most deadly of all of the solid malignancies. On the other hand, the neoplastic glands can be remarkably well-differentiated, and it can be difficult to distinguish between a reactive non-neoplastic gland and a gland of invasive adenocarcinoma. In this review, we will present diagnostic criteria that one can "hang your hat on" when establishing the diagnosis of infiltrating ductal adenocarcinoma of the pancreas. We will also review clinically important features of the disease, and, with the impending incorporation of molecular genetics into everyday practice, we will emphasize clinical applications of cancer genetics.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Adenocarcinoma; Pancreas; Pancreas cancer; Pancreatic cancer

Mesh:

Year:  2014        PMID: 25441308      PMCID: PMC4313868          DOI: 10.1053/j.semdp.2014.08.004

Source DB:  PubMed          Journal:  Semin Diagn Pathol        ISSN: 0740-2570            Impact factor:   3.464


  48 in total

1.  Immunohistochemical labeling for dpc4 mirrors genetic status in pancreatic adenocarcinomas : a new marker of DPC4 inactivation.

Authors:  R E Wilentz; G H Su; J L Dai; A B Sparks; P Argani; T A Sohn; C J Yeo; S E Kern; R H Hruban
Journal:  Am J Pathol       Date:  2000-01       Impact factor: 4.307

2.  Increased Prevalence of Precursor Lesions in Familial Pancreatic Cancer Patients.

Authors:  Chanjuan Shi; Alison P Klein; Michael Goggins; Anirban Maitra; Marcia Canto; Syed Ali; Richard Schulick; Emily Palmisano; Ralph H Hruban
Journal:  Clin Cancer Res       Date:  2009-12-15       Impact factor: 12.531

3.  Benign epithelial inclusions in pancreatic nerves.

Authors:  J Costa
Journal:  Am J Clin Pathol       Date:  1977-03       Impact factor: 2.493

4.  A meta-analysis of gemcitabine biomarkers in patients with pancreaticobiliary cancers.

Authors:  Christina H Wei; Tristan R Gorgan; David A Elashoff; O Joe Hines; James J Farrell; Timothy R Donahue
Journal:  Pancreas       Date:  2013-11       Impact factor: 3.327

5.  Personalizing cancer treatment in the age of global genomic analyses: PALB2 gene mutations and the response to DNA damaging agents in pancreatic cancer.

Authors:  Maria C Villarroel; N V Rajeshkumar; Ignacio Garrido-Laguna; Ana De Jesus-Acosta; Siân Jones; Anirban Maitra; Ralph H Hruban; James R Eshleman; Alison Klein; Daniel Laheru; Ross Donehower; Manuel Hidalgo
Journal:  Mol Cancer Ther       Date:  2010-12-06       Impact factor: 6.261

6.  Recurrent GNAS mutations define an unexpected pathway for pancreatic cyst development.

Authors:  Jian Wu; Hanno Matthaei; Anirban Maitra; Marco Dal Molin; Laura D Wood; James R Eshleman; Michael Goggins; Marcia I Canto; Richard D Schulick; Barish H Edil; Christopher L Wolfgang; Alison P Klein; Luis A Diaz; Peter J Allen; C Max Schmidt; Kenneth W Kinzler; Nickolas Papadopoulos; Ralph H Hruban; Bert Vogelstein
Journal:  Sci Transl Med       Date:  2011-07-20       Impact factor: 17.956

Review 7.  An illustrated consensus on the classification of pancreatic intraepithelial neoplasia and intraductal papillary mucinous neoplasms.

Authors:  Ralph H Hruban; Kyoichi Takaori; David S Klimstra; N Volkan Adsay; Jorge Albores-Saavedra; Andrew V Biankin; Sandra A Biankin; Carolyn Compton; Noriyoshi Fukushima; Toru Furukawa; Michael Goggins; Yo Kato; Gunter Klöppel; Daniel S Longnecker; Jutta Lüttges; Anirban Maitra; G Johan A Offerhaus; Michio Shimizu; Suguru Yonezawa
Journal:  Am J Surg Pathol       Date:  2004-08       Impact factor: 6.394

8.  Risk of pancreatic cancer in families with Lynch syndrome.

Authors:  Fay Kastrinos; Bhramar Mukherjee; Nabihah Tayob; Fei Wang; Jennifer Sparr; Victoria M Raymond; Prathap Bandipalliam; Elena M Stoffel; Stephen B Gruber; Sapna Syngal
Journal:  JAMA       Date:  2009-10-28       Impact factor: 56.272

9.  SMAD4 gene mutations are associated with poor prognosis in pancreatic cancer.

Authors:  Amanda Blackford; Oscar K Serrano; Christopher L Wolfgang; Giovanni Parmigiani; Siân Jones; Xiaosong Zhang; D Williams Parsons; Jimmy Cheng-Ho Lin; Rebecca J Leary; James R Eshleman; Michael Goggins; Elizabeth M Jaffee; Christine A Iacobuzio-Donahue; Anirban Maitra; John L Cameron; Kelly Olino; Richard Schulick; Jordan Winter; Joseph M Herman; Daniel Laheru; Alison P Klein; Bert Vogelstein; Kenneth W Kinzler; Victor E Velculescu; Ralph H Hruban
Journal:  Clin Cancer Res       Date:  2009-07-07       Impact factor: 12.531

10.  Somatic mutations in the chromatin remodeling gene ARID1A occur in several tumor types.

Authors:  Siân Jones; Meng Li; D Williams Parsons; Xiaosong Zhang; Jelle Wesseling; Petra Kristel; Marjanka K Schmidt; Sanford Markowitz; Hai Yan; Darell Bigner; Ralph H Hruban; James R Eshleman; Christine A Iacobuzio-Donahue; Michael Goggins; Anirban Maitra; Sami N Malek; Steve Powell; Bert Vogelstein; Kenneth W Kinzler; Victor E Velculescu; Nickolas Papadopoulos
Journal:  Hum Mutat       Date:  2011-11-23       Impact factor: 4.878

View more
  12 in total

1.  Mutational spectrum of intraepithelial neoplasia in pancreatic heterotopia.

Authors:  Changqing Ma; Christopher D Gocke; Ralph H Hruban; Deborah A Belchis
Journal:  Hum Pathol       Date:  2015-10-09       Impact factor: 3.466

2.  A Revised Classification System and Recommendations From the Baltimore Consensus Meeting for Neoplastic Precursor Lesions in the Pancreas.

Authors:  Olca Basturk; Seung-Mo Hong; Laura D Wood; N Volkan Adsay; Jorge Albores-Saavedra; Andrew V Biankin; Lodewijk A A Brosens; Noriyoshi Fukushima; Michael Goggins; Ralph H Hruban; Yo Kato; David S Klimstra; Günter Klöppel; Alyssa Krasinskas; Daniel S Longnecker; Hanno Matthaei; G Johan A Offerhaus; Michio Shimizu; Kyoichi Takaori; Benoit Terris; Shinichi Yachida; Irene Esposito; Toru Furukawa
Journal:  Am J Surg Pathol       Date:  2015-12       Impact factor: 6.394

3.  Validation of a Proposed Tumor Regression Grading Scheme for Pancreatic Ductal Adenocarcinoma After Neoadjuvant Therapy as a Prognostic Indicator for Survival.

Authors:  Sun Mi Lee; Matthew H G Katz; Li Liu; Manonmani Sundar; Hua Wang; Gauri R Varadhachary; Robert A Wolff; Jeffrey E Lee; Anirban Maitra; Jason B Fleming; Asif Rashid; Huamin Wang
Journal:  Am J Surg Pathol       Date:  2016-12       Impact factor: 6.394

4.  p16, p21, and p53 proteins play an important role in development of pancreatic intraepithelial neoplastic.

Authors:  Justyna Zińczuk; Konrad Zaręba; Katarzyna Guzińska-Ustymowicz; Bogusław Kędra; Andrzej Kemona; Anna Pryczynicz
Journal:  Ir J Med Sci       Date:  2018-02-01       Impact factor: 1.568

5.  Immunolabeling of Cleared Human Pancreata Provides Insights into Three-Dimensional Pancreatic Anatomy and Pathology.

Authors:  Michaël Noë; Neda Rezaee; Kaushal Asrani; Michael Skaro; Vincent P Groot; Pei-Hsun Wu; Matthew T Olson; Seung-Mo Hong; Sung Joo Kim; Matthew J Weiss; Christopher L Wolfgang; Martin A Makary; Jin He; John L Cameron; Denis Wirtz; Nicholas J Roberts; G Johan A Offerhaus; Lodewijk A A Brosens; Laura D Wood; Ralph H Hruban
Journal:  Am J Pathol       Date:  2018-04-22       Impact factor: 4.307

6.  Conditioned media of pancreatic cancer cells and pancreatic stellate cells induce myeloid-derived suppressor cells differentiation and lymphocytes suppression.

Authors:  Yuen Ping Chong; Evelyn Priya Peter; Feon Jia Ming Lee; Chu Mun Chan; Shereen Chai; Lorni Poh Chou Ling; Eng Lai Tan; Sook Han Ng; Atsushi Masamune; Siti Aisyah Abd Ghafar; Norsharina Ismail; Ket Li Ho
Journal:  Sci Rep       Date:  2022-07-19       Impact factor: 4.996

Review 7.  [Ductal adenocarcinoma and unusual differential diagnosis].

Authors:  P Haage; C A Schwartz; C Scharwächter
Journal:  Radiologe       Date:  2016-04       Impact factor: 0.635

8.  Radiotherapy and CD40 Activation Separately Augment Immunity to Checkpoint Blockade in Cancer.

Authors:  Christina Twyman-Saint Victor; Robert H Vonderheide; Andrew J Rech; Hannah Dada; Jonathan J Kotzin; Jorge Henao-Mejia; Andy J Minn
Journal:  Cancer Res       Date:  2018-05-29       Impact factor: 12.701

9.  Downregulation of 5-hydroxymethylcytosine is an early event in pancreatic tumorigenesis.

Authors:  Kohei Fujikura; Zainab I Alruwaii; Michael C Haffner; Maria A Trujillo; Nicholas J Roberts; Seung-Mo Hong; Anne Macgregor-Das; Michael G Goggins; Sujayita Roy; Alan K Meeker; Ding Ding; Michael Wright; Jin He; Ralph H Hruban; Laura D Wood
Journal:  J Pathol       Date:  2021-05-21       Impact factor: 9.883

Review 10.  Basics and Frontiers on Pancreatic Cancer for Radiation Oncology: Target Delineation, SBRT, SIB technique, MRgRT, Particle Therapy, Immunotherapy and Clinical Guidelines.

Authors:  Francesco Cellini; Alessandra Arcelli; Nicola Simoni; Luciana Caravatta; Milly Buwenge; Angela Calabrese; Oronzo Brunetti; Domenico Genovesi; Renzo Mazzarotto; Francesco Deodato; Gian Carlo Mattiucci; Nicola Silvestris; Vincenzo Valentini; Alessio Giuseppe Morganti
Journal:  Cancers (Basel)       Date:  2020-06-29       Impact factor: 6.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.